Reactivation of latent viral hepatitis infection in patients of chronic myeloid leukemia treated with imatinib mesylate: Experience from a tertiary cancer center in India.

被引：0
|
作者：
Ostwal, V. [1 ]
Ghadyalpatil, N. [1 ]
Prabhash, K. [1 ]
Menon, H. [1 ]
Nair, R. [1 ]
Sengar, M. [1 ]
Noronha, V. [1 ]
Biswas, S. [1 ]
Bhosale, B. [1 ]
Banavali, S. [1 ]
机构：
[1] Tata Mem Hosp, Bombay 400012, Maharashtra, India
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2010年 / 28卷 / 15期
关键词：
D O I：
10.1200/jco.2010.28.15_suppl.6593
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
6593
引用
收藏
页数：1
相关论文
共 50 条
  • [1] HEPATITIS B REACTIVATION IN THE CHRONIC MYELOID LEUKEMIA PATIENT TREATED WITH IMATINIB MESYLATE
    Ozeki, Kazutaka
    Morishita, Yoshihisa
    Suzuki, Tomohiko
    Umemura, Koji
    Yamaguchi, Yohei
    Tatekawa, Shotaro
    Watamoto, Koichi
    Ozeki, Keiji
    Kohno, Akio
    ANNALS OF ONCOLOGY, 2014, 25
  • [2] Hepatitis B virus reactivation in a chronic myeloid leukemia patient treated with imatinib mesylate
    GOWREA Bhuveshwamath
    中华医学杂志（英文版）, 2012, (14) : 2636 - 2637
  • [3] Hepatitis B virus reactivation in a chronic myeloid leukemia patient treated with imatinib mesylate
    Wang Ya-dan
    Cui Guo-hui
    Li Mian
    Gowrea, Bhuveshwarnath
    Xia Jia
    Hu Yu
    CHINESE MEDICAL JOURNAL, 2012, 125 (14) : 2636 - 2637
  • [4] Tolerance of imatinib mesylate in chronic myeloid leukemia and gastrointestinal stromal tumours patients: an experience from India
    Mukhopadhyay, A
    Barman, B
    Sen, A
    Sarkar, S
    Gupta, P
    Deb, A
    Mukhopadhyay, S
    ANNALS OF ONCOLOGY, 2005, 16 : 304 - 304
  • [5] Clinical and pharmacokinetic profile of Imatinib mesylate in the treatment of chronic myeloid leukemia (CML): Results from a large center in Northern India.
    Arora, B
    Kumari, M
    Kumar, L
    Velpadian, T
    Gupta, SK
    Kouchupillai, V
    Sharma, A
    Wadhwa, J
    Bhutani, M
    Seth, T
    BLOOD, 2003, 102 (11) : 315B - 315B
  • [6] Results of imatinib mesylate therapy in chronic myeloid leukemia: Experience of a single center
    Pasa, S.
    Boyraz, T.
    Beyaz, C.
    Sayar, S.
    Atayan, Y.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 530 - 530
  • [7] Pigmentary changes in chronic myeloid leukemia patients treated with imatinib mesylate
    Arora, B
    Kumar, L
    Sharma, A
    Wadhwa, J
    Kochupillai, V
    ANNALS OF ONCOLOGY, 2004, 15 (02) : 358 - 359
  • [8] Cytogenetic responses in chronic myeloid leukemia patients treated with imatinib mesylate
    Babameto-Laku, A.
    Mokin, V.
    Cikuli, M.
    Xhumari, P.
    CHROMOSOME RESEARCH, 2005, 13 : 158 - 158
  • [9] Nutritional Status of Patients with Chronic Myeloid Leukemia Treated with Imatinib Mesylate
    Jose Castillo-Martinez, Maria
    Juventina Tuna-Aguilar, Elena
    del Pilar Milke-Garcia, Maria
    Camacho Zamora, Anais
    Villegas Cervantes, Viviana
    Castillo-Martinez, Lilia
    NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL, 2022, 74 (09): : 3211 - 3216
  • [10] Imatinib Mesylate Therapy in Patients of Chronic Myeloid Leukemia with Philadelphia Chromosome Positive: An Experience from Eastern India
    A. Mukhopadhyay
    S. Dasgupta
    S. Mukhopadhyay
    C. K. Bose
    S. Sarkar
    F. Gharami
    S. Koner
    J. Basak
    U. K. Roy
    Indian Journal of Hematology and Blood Transfusion, 2012, 28 : 82 - 88
12345